Naloxone D5


This is a Controlled Substance.
For exact pricing and delivery please contact
Product Details

CAT No.# CS-O-06798
Category Stable Isotopes
CAS 1261079-38-2
Molecular Weight 332.41
Molecular Formula C19H16D5NO4
Stock Status: In-Stock
Purity: 99.54
Solubility: Chloroform, Methanol
Appearance: White to Off-White Solid
Synonyms: 5α)-4,5-Epoxy-3,14-dihydroxy-17-(2-propenyl-d5)morphinan-6-one Hydrochloride; 17-Allyl-4,5α-epoxy-3,14-dihydroxymorphinan-6-one-d5 Hydrochloride; Nalone-d5; Narcan-d5; Narcanti-d5; EN-15304-d5
Application Notes: Labelled specific opioid antagonist. Narcotic antagonist. Intended for use as an internal standard for the quantification of Naloxone by GC- or LC-mass spectrometry.
References: Jasinski, D.R., et al.: J. Pharmacol. Exp. Ther., 157, 420 (1967); McNicholas, L.F., et al.: Drugs, 27, 81 (1984); Hasson, M.M.A., et al.: Anal. Profiles Drug Subs., 14, 453 (1985); Stowe, C., et al.: Ann. Pharmacother., 27, 447 (1993)
Storage: -20° C
COA / MSDS:    View COA    MSDS    Enquire
The balance used are calibrated with weights traceable to National Standards NIST for accuracy
PEOPLE ALSO SEARCHED FOR: 1. (6R,7S)-7-(2-chloroacetamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
2. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
3. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
4. Benidipine D7
5. Lauroside D
6. Triazolam 13C D3
7. Icatibant impurity 1
9. 0.1% TFA in Water ULC-MS
10. Metamizole EP Impurity C HCl
11. Silodosin Metabolite D4
12. Brivaracetam Carboxylic acid metabolite [UCB 42145]
13. Terbuthylazine D5
14. tibolone (848)
15. (Z)-Dimethylvinphos
16. Silodosin Metabolite
17. 2-Phenoxymethanesulfonanilide
18. Nimesulide EP Impurity A
19. Acetone HPLC
20. Nandrolone Decanoate EP impurity F


This page contains information about Naloxone D5 Cas 1261079-38-2 and its Stable Isotopes.
"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."